Global Hepatitis A Vaccine Market Research Report 2026(Status and Outlook)

May 2026 | 136 pages | ID: G532300C5FB8EN
Bosson Research

Abstracts

Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.

The global Hepatitis A Vaccine market size was estimated at USD 751.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 2.20% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Hepatitis A Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Hepatitis A Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hepatitis A Vaccine market.

Global Hepatitis A Vaccine Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GSK
• Merck
• Sanofi
• Sinovac
• Zhejiang Pukang
• Changchun Institute of Biological
• KM Biologics
• IMBCAMS
• Convac

Market Segmentation (by Type)

• Inactivated Vaccine
• Live Attenuated Vaccine

Market Segmentation (by Application)

• Government Institution
• Private Sector
• Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hepatitis A Vaccine Market

Overview of the regional outlook of the Hepatitis A Vaccine Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hepatitis A Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Hepatitis A Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Hepatitis A Vaccine
1.2 Key Market Segments
  1.2.1 Hepatitis A Vaccine Segment by Type
  1.2.2 Hepatitis A Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 HEPATITIS A VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Hepatitis A Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Hepatitis A Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 HEPATITIS A VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Hepatitis A Vaccine Product Life Cycle
3.3 Global Hepatitis A Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hepatitis A Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Hepatitis A Vaccine Market Competitive Situation and Trends
  3.8.1 Hepatitis A Vaccine Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Hepatitis A Vaccine Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 HEPATITIS A VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Hepatitis A Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF HEPATITIS A VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Hepatitis A Vaccine Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Hepatitis A Vaccine Market
5.7 ESG Ratings of Leading Companies

6 HEPATITIS A VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Hepatitis A Vaccine Market Size by Type (2020-2025)
6.4 Global Hepatitis A Vaccine Price by Type (2020-2025)

7 HEPATITIS A VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hepatitis A Vaccine Market Sales by Application (2020-2025)
7.3 Global Hepatitis A Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Hepatitis A Vaccine Sales Growth Rate by Application (2020-2025)

8 HEPATITIS A VACCINE MARKET SALES BY REGION

8.1 Global Hepatitis A Vaccine Sales by Region
  8.1.1 Global Hepatitis A Vaccine Sales by Region
  8.1.2 Global Hepatitis A Vaccine Sales Market Share by Region
8.2 Global Hepatitis A Vaccine Market Size by Region
  8.2.1 Global Hepatitis A Vaccine Market Size by Region
  8.2.2 Global Hepatitis A Vaccine Market Size by Region
8.3 North America
  8.3.1 North America Hepatitis A Vaccine Sales by Country
  8.3.2 North America Hepatitis A Vaccine Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Hepatitis A Vaccine Sales by Country
  8.4.2 Europe Hepatitis A Vaccine Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Hepatitis A Vaccine Sales by Region
  8.5.2 Asia Pacific Hepatitis A Vaccine Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Hepatitis A Vaccine Sales by Country
  8.6.2 South America Hepatitis A Vaccine Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Hepatitis A Vaccine Sales by Region
  8.7.2 Middle East and Africa Hepatitis A Vaccine Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 HEPATITIS A VACCINE MARKET PRODUCTION BY REGION

9.1 Global Production of Hepatitis A Vaccine by Region(2020-2025)
9.2 Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Hepatitis A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hepatitis A Vaccine Production
  9.4.1 North America Hepatitis A Vaccine Production Growth Rate (2020-2025)
  9.4.2 North America Hepatitis A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hepatitis A Vaccine Production
  9.5.1 Europe Hepatitis A Vaccine Production Growth Rate (2020-2025)
  9.5.2 Europe Hepatitis A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hepatitis A Vaccine Production (2020-2025)
  9.6.1 Japan Hepatitis A Vaccine Production Growth Rate (2020-2025)
  9.6.2 Japan Hepatitis A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hepatitis A Vaccine Production (2020-2025)
  9.7.1 China Hepatitis A Vaccine Production Growth Rate (2020-2025)
  9.7.2 China Hepatitis A Vaccine Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GSK
  10.1.1 GSK Basic Information
  10.1.2 GSK Hepatitis A Vaccine Product Overview
  10.1.3 GSK Hepatitis A Vaccine Product Market Performance
  10.1.4 GSK Business Overview
  10.1.5 GSK SWOT Analysis
  10.1.6 GSK Recent Developments
10.2 Merck
  10.2.1 Merck Basic Information
  10.2.2 Merck Hepatitis A Vaccine Product Overview
  10.2.3 Merck Hepatitis A Vaccine Product Market Performance
  10.2.4 Merck Business Overview
  10.2.5 Merck SWOT Analysis
  10.2.6 Merck Recent Developments
10.3 Sanofi
  10.3.1 Sanofi Basic Information
  10.3.2 Sanofi Hepatitis A Vaccine Product Overview
  10.3.3 Sanofi Hepatitis A Vaccine Product Market Performance
  10.3.4 Sanofi Business Overview
  10.3.5 Sanofi SWOT Analysis
  10.3.6 Sanofi Recent Developments
10.4 Sinovac
  10.4.1 Sinovac Basic Information
  10.4.2 Sinovac Hepatitis A Vaccine Product Overview
  10.4.3 Sinovac Hepatitis A Vaccine Product Market Performance
  10.4.4 Sinovac Business Overview
  10.4.5 Sinovac Recent Developments
10.5 Zhejiang Pukang
  10.5.1 Zhejiang Pukang Basic Information
  10.5.2 Zhejiang Pukang Hepatitis A Vaccine Product Overview
  10.5.3 Zhejiang Pukang Hepatitis A Vaccine Product Market Performance
  10.5.4 Zhejiang Pukang Business Overview
  10.5.5 Zhejiang Pukang Recent Developments
10.6 Changchun Institute of Biological
  10.6.1 Changchun Institute of Biological Basic Information
  10.6.2 Changchun Institute of Biological Hepatitis A Vaccine Product Overview
  10.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product Market Performance
  10.6.4 Changchun Institute of Biological Business Overview
  10.6.5 Changchun Institute of Biological Recent Developments
10.7 KM Biologics
  10.7.1 KM Biologics Basic Information
  10.7.2 KM Biologics Hepatitis A Vaccine Product Overview
  10.7.3 KM Biologics Hepatitis A Vaccine Product Market Performance
  10.7.4 KM Biologics Business Overview
  10.7.5 KM Biologics Recent Developments
10.8 IMBCAMS
  10.8.1 IMBCAMS Basic Information
  10.8.2 IMBCAMS Hepatitis A Vaccine Product Overview
  10.8.3 IMBCAMS Hepatitis A Vaccine Product Market Performance
  10.8.4 IMBCAMS Business Overview
  10.8.5 IMBCAMS Recent Developments
10.9 Convac
  10.9.1 Convac Basic Information
  10.9.2 Convac Hepatitis A Vaccine Product Overview
  10.9.3 Convac Hepatitis A Vaccine Product Market Performance
  10.9.4 Convac Business Overview
  10.9.5 Convac Recent Developments

11 HEPATITIS A VACCINE MARKET FORECAST BY REGION

11.1 Global Hepatitis A Vaccine Market Size Forecast
11.2 Global Hepatitis A Vaccine Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Hepatitis A Vaccine Market Size Forecast by Country
  11.2.3 Asia Pacific Hepatitis A Vaccine Market Size Forecast by Region
  11.2.4 South America Hepatitis A Vaccine Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Hepatitis A Vaccine by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Hepatitis A Vaccine Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Hepatitis A Vaccine by Type (2026-2035)
  12.1.2 Global Hepatitis A Vaccine Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Hepatitis A Vaccine by Type (2026-2035)
12.2 Global Hepatitis A Vaccine Market Forecast by Application (2026-2035)
  12.2.1 Global Hepatitis A Vaccine Sales (K MT) Forecast by Application
  12.2.2 Global Hepatitis A Vaccine Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hepatitis A Vaccine Market Size by Type (M USD)
Table 4. Global Hepatitis A Vaccine Market Size by Application
Table 5. Hepatitis A Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Hepatitis A Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hepatitis A Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hepatitis A Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Vaccine as of 2025)
Table 11. Global Market Hepatitis A Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Hepatitis A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hepatitis A Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hepatitis A Vaccine Sales by Type (K MT)
Table 27. Global Hepatitis A Vaccine Market Size by Type (M USD)
Table 28. Global Hepatitis A Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Hepatitis A Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Hepatitis A Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Hepatitis A Vaccine Market Share by Type (2020-2025)
Table 32. Global Hepatitis A Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Hepatitis A Vaccine Sales (K MT) by Application
Table 34. Global Hepatitis A Vaccine Market Size by Application
Table 35. Global Hepatitis A Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Hepatitis A Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hepatitis A Vaccine Market Share by Application (2020-2025)
Table 39. Global Hepatitis A Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Hepatitis A Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Hepatitis A Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Hepatitis A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hepatitis A Vaccine Market Size by Region (2020-2025)
Table 44. North America Hepatitis A Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Hepatitis A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hepatitis A Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hepatitis A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hepatitis A Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hepatitis A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hepatitis A Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Hepatitis A Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hepatitis A Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hepatitis A Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hepatitis A Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Hepatitis A Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hepatitis A Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hepatitis A Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GSK Basic Information
Table 63. GSK Hepatitis A Vaccine Product Overview
Table 64. GSK Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GSK Business Overview
Table 66. GSK SWOT Analysis
Table 67. GSK Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Hepatitis A Vaccine Product Overview
Table 70. Merck Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi Hepatitis A Vaccine Product Overview
Table 76. Sanofi Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. Sinovac Basic Information
Table 81. Sinovac Hepatitis A Vaccine Product Overview
Table 82. Sinovac Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sinovac Business Overview
Table 84. Sinovac Recent Developments
Table 85. Zhejiang Pukang Basic Information
Table 86. Zhejiang Pukang Hepatitis A Vaccine Product Overview
Table 87. Zhejiang Pukang Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Zhejiang Pukang Business Overview
Table 89. Zhejiang Pukang Recent Developments
Table 90. Changchun Institute of Biological Basic Information
Table 91. Changchun Institute of Biological Hepatitis A Vaccine Product Overview
Table 92. Changchun Institute of Biological Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Changchun Institute of Biological Business Overview
Table 94. Changchun Institute of Biological Recent Developments
Table 95. KM Biologics Basic Information
Table 96. KM Biologics Hepatitis A Vaccine Product Overview
Table 97. KM Biologics Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. KM Biologics Business Overview
Table 99. KM Biologics Recent Developments
Table 100. IMBCAMS Basic Information
Table 101. IMBCAMS Hepatitis A Vaccine Product Overview
Table 102. IMBCAMS Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. IMBCAMS Business Overview
Table 104. IMBCAMS Recent Developments
Table 105. Convac Basic Information
Table 106. Convac Hepatitis A Vaccine Product Overview
Table 107. Convac Hepatitis A Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Convac Business Overview
Table 109. Convac Recent Developments
Table 110. Global Hepatitis A Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 111. Global Hepatitis A Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 112. North America Hepatitis A Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 113. North America Hepatitis A Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Europe Hepatitis A Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 115. Europe Hepatitis A Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 116. Asia Pacific Hepatitis A Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 117. Asia Pacific Hepatitis A Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. South America Hepatitis A Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 119. South America Hepatitis A Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Middle East and Africa Hepatitis A Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 121. Middle East and Africa Hepatitis A Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Global Hepatitis A Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 123. Global Hepatitis A Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 124. Global Hepatitis A Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 125. Global Hepatitis A Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 126. Global Hepatitis A Vaccine Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Hepatitis A Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hepatitis A Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Hepatitis A Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Hepatitis A Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hepatitis A Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hepatitis A Vaccine Product Life Cycle
Figure 13. Hepatitis A Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Hepatitis A Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Hepatitis A Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hepatitis A Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hepatitis A Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Hepatitis A Vaccine
Figure 19. Global Hepatitis A Vaccine Market PEST Analysis
Figure 20. Global Hepatitis A Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hepatitis A Vaccine Market Share by Type
Figure 27. Sales Market Share of Hepatitis A Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Hepatitis A Vaccine by Type in 2025
Figure 29. Market Share of Hepatitis A Vaccine by Type (2020-2025)
Figure 30. Market Share of Hepatitis A Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hepatitis A Vaccine Market Share by Application
Figure 33. Global Hepatitis A Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Hepatitis A Vaccine Sales Market Share by Application in 2025
Figure 35. Global Hepatitis A Vaccine Market Share by Application (2020-2025)
Figure 36. Global Hepatitis A Vaccine Market Share by Application in 2025
Figure 37. Global Hepatitis A Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hepatitis A Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Hepatitis A Vaccine Market Size by Region (2020-2025)
Figure 40. North America Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hepatitis A Vaccine Sales Market Share by Country in 2024
Figure 43. North America Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hepatitis A Vaccine Market Size by Country in 2024
Figure 45. U.S. Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hepatitis A Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hepatitis A Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hepatitis A Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hepatitis A Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hepatitis A Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hepatitis A Vaccine Market Size by Country in 2024
Figure 55. Germany Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hepatitis A Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hepatitis A Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hepatitis A Vaccine Market Size by Region in 2024
Figure 68. China Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hepatitis A Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Hepatitis A Vaccine Sales Market Share by Country in 2024
Figure 80. South America Hepatitis A Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Hepatitis A Vaccine Market Size by Country in 2024
Figure 82. Brazil Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hepatitis A Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hepatitis A Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hepatitis A Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hepatitis A Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hepatitis A Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hepatitis A Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hepatitis A Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Hepatitis A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hepatitis A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hepatitis A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hepatitis A Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hepatitis A Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hepatitis A Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hepatitis A Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hepatitis A Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Hepatitis A Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Hepatitis A Vaccine Market Share Forecast by Application (2026-2035)